From the Department of Medicine (W.M.O., R.K.F.O., R.-S.W., D.M.R., B.M.W., C.A.M., J.L., A.B.W., D.M.S., J.A.L.), Division of Pulmonary and Critical Care Medicine (W.M.O., B.M.W., A.B.W., D.M.S.), Division of Cardiovascular Medicine (A.R.O., C.A.M., J.L., J.A.L., B.A.M.), and Department of Radiology (J.H.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Division of Respiratory Diseases, Department of Medicine, Federal University of São Paulo (UNIFESP), Brazil (R.K.F.O.); Department of Cardiology, Boston Children's Hospital and Harvard Medical School, MA (A.R.O.); Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (G.A.A.); Division of Cardiology, Department of Medicine, Providence Veterans Affairs Medical Center and Alpert Medical School of Brown University, Providence, RI (G.C.); Department of Pulmonology, Medical University of Graz, Austria (A.T., H.O., G.K.); Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria (A.T., H.O., G.K.); and Department of Cardiology, Boston VA Healthcare System, MA (B.A.M.).
Circ Res. 2018 Mar 16;122(6):864-876. doi: 10.1161/CIRCRESAHA.117.312482. Epub 2018 Feb 5.
Current methods assessing clinical risk because of exercise intolerance in patients with cardiopulmonary disease rely on a small subset of traditional variables. Alternative strategies incorporating the spectrum of factors underlying prognosis in at-risk patients may be useful clinically, but are lacking.
Use unbiased analyses to identify variables that correspond to clinical risk in patients with exercise intolerance.
Data from 738 consecutive patients referred for invasive cardiopulmonary exercise testing at a single center (2011-2015) were analyzed retrospectively (derivation cohort). A correlation network of invasive cardiopulmonary exercise testing parameters was assembled using |r|>0.5. From an exercise network of 39 variables (ie, nodes) and 98 correlations (ie, edges) corresponding to <9.5e for each correlation, we focused on a subnetwork containing peak volume of oxygen consumption (pVo) and 9 linked nodes. K-mean clustering based on these 10 variables identified 4 novel patient clusters characterized by significant differences in 44 of 45 exercise measurements (<0.01). Compared with a probabilistic model, including 23 independent predictors of pVo and pVo itself, the network model was less redundant and identified clusters that were more distinct. Cluster assignment from the network model was predictive of subsequent clinical events. For example, a 4.3-fold (<0.0001; 95% CI, 2.2-8.1) and 2.8-fold (=0.0018; 95% CI, 1.5-5.2) increase in hazard for age- and pVo-adjusted all-cause 3-year hospitalization, respectively, were observed between the highest versus lowest risk clusters. Using these data, we developed the first risk-stratification calculator for patients with exercise intolerance. When applying the risk calculator to patients in 2 independent invasive cardiopulmonary exercise testing cohorts (Boston and Graz, Austria), we observed a clinical risk profile that paralleled the derivation cohort.
Network analyses were used to identify novel exercise groups and develop a point-of-care risk calculator. These data expand the range of useful clinical variables beyond pVo that predict hospitalization in patients with exercise intolerance.
目前评估心肺疾病患者运动不耐受相关临床风险的方法依赖于一小部分传统变量。纳入高危患者预后相关因素谱的替代策略可能具有临床意义,但目前仍缺乏这些策略。
采用无偏分析方法识别与运动不耐受患者临床风险相关的变量。
对单中心(2011-2015 年)连续 738 例进行有创心肺运动试验的患者数据进行回顾性分析(推导队列)。采用 |r|>0.5 构建有创心肺运动试验参数相关联网络。从包含 39 个变量(即节点)和 98 个相关(即边)的运动网络(即,<9.5e 对应于每个相关)中,我们关注包含峰值摄氧量(pVo)和 9 个连接节点的子网络。基于这 10 个变量的 K-均值聚类确定了 4 个新的患者聚类,这 4 个聚类在 45 项运动测量中存在 44 项有统计学意义的差异(<0.01)。与包含 pVo 和 pVo 自身 23 个独立预测因子的概率模型相比,网络模型的冗余度更小,聚类也更独特。网络模型的聚类分配可预测随后的临床事件。例如,在最高与最低风险聚类之间,年龄和 pVo 校正后的全因 3 年住院风险分别增加 4.3 倍(<0.0001;95%CI,2.2-8.1)和 2.8 倍(=0.0018;95%CI,1.5-5.2)。利用这些数据,我们为运动不耐受患者开发了首个风险分层计算器。当将风险计算器应用于 2 个独立的有创心肺运动试验队列(波士顿和奥地利格拉茨)的患者时,我们观察到与推导队列相似的临床风险特征。
采用网络分析方法识别新的运动组,并开发即时护理风险计算器。这些数据扩展了预测运动不耐受患者住院的有用临床变量范围,超越了峰值摄氧量。